Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

http://www.wikidata.org/entity/Q37682510

about

Exosomes as Novel Regulators of Adult Neurogenic Niches Neuroimmune pharmacological approaches Preventive health measures in inflammatory bowel disease Inflammatory bowel disease and anxiety: links, risks, and challenges faced Gastroenterology issues in schizophrenia: why the gut matters.Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease Effect of venlafaxine on experimental colitis in normal and reserpinised depressed rats.The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease.High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia.The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.Using murine colitis models to analyze probiotics-host interactions.Evaluating [11C]PBR28 PET for Monitoring Gut and Brain Inflammation in a Rat Model of Chemically Induced Colitis.Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease.Editorial: yoga for QoL in ulcerative colitis-any better than other supportive activities? Authors' reply.The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation.Psychobiotics: The Potential Therapeutic Promise of Microbes in Psychiatry Alexithymia and Psychopathology in Patients Suffering From Inflammatory Bowel Disease: Arising Differences and Correlations to Tailoring Therapeutic Strategies

P2860

Q26772836-FEA5D630-4831-458A-890F-88E9133CB313 Q26782927-73E816B8-349F-46B5-B615-5D4F7C668C48 Q28078112-BBB8FB91-F92C-49B9-9667-595DD79A46AE Q35222879-DCC72C11-1103-498C-A660-26FFAAB5B2BB Q35577667-B50E328F-5FC1-4292-BA77-076271D63CA8 Q35692347-BDF9E1BF-DC16-41BE-8B70-88C8D848A1AA Q36216726-F82A91F8-3305-4F87-B122-ABC2A2FF43E3 Q36757400-03AB4F24-4D7C-4EAF-BD32-C2868703C4BC Q38620028-2430AB6D-D7D7-4866-87F3-8C9AA576CC7B Q38649487-C197C880-4E34-4E1B-A987-FD9507C1B5A2 Q38955820-0D3F69C9-FFA2-496F-B207-44DA178B0DF8 Q40084224-904639BA-26B2-451E-A2EB-9805759C6F4A Q40630941-4BB89681-9E46-4E42-8442-B14EEF98DA17 Q46022482-10FA0B99-8123-4FE1-864D-46CD1CDD4E57 Q47558224-194EA57A-310D-4C8B-8467-C71175CDDC84 Q47765177-C5A5557D-C228-4CD0-8200-584AB2E81910 Q47886912-1DC89015-EB70-4066-A4E3-870D7E6BAE19 Q54217096-B1ABB5CA-4759-4D6B-913B-477FC6BAA515 Q55001002-6A1155A5-D9E2-4255-9289-9D039735D12E Q57820185-06608DDC-7B5E-4575-822F-81F9D6933376 Q58801461-1FE89F14-3AC3-4CE5-AB38-A71CC2D1D152

P2860

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

http://www.wikidata.org/entity/Q37682510

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

@en

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

@nl

type

label

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

@en

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

@nl

prefLabel

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

@en

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

@nl

P1433

Q37682510-E9518B5D-9091-4489-A8A7-814CFB0936E6

P1476

Q37682510-70E35C98-A604-4979-88DA-3727A145158F

P2093

Q37682510-3E86D316-A6C1-4417-8362-C4E1CBB81527

Q37682510-64FF7B76-C7F6-45FC-8162-321C49E2CC44

P2860

Q37682510-008218FE-184C-4CE6-937B-EDE85FED0A8E

Q37682510-03FFF81F-C6D8-4A2C-A085-33A316936BD5

Q37682510-040E1996-D040-4B05-B3CD-EE8EF1A4E1AF

Q37682510-0486EF33-C531-4AED-9884-85904E097F6B

Q37682510-0775F9F5-7808-49C0-87C1-9A5A22100F9A

Q37682510-083E1F2F-EABE-429E-A472-74F38153DF03

Q37682510-09389170-52D2-469F-8C4F-F98745A1CE7D

Q37682510-0BE7E7C7-A790-42D5-8374-790C1D228DB4

Q37682510-0E09F8FC-A76A-4629-97E4-D0312646004F

Q37682510-0E33139C-D1FE-4FC6-9C40-DC3CF5050B78

P304

Q37682510-BC283440-E472-4DC6-B9B0-EA6DF861C7B9

P31

Q37682510-CB303899-277D-464D-A6E6-1E5992AC9291

P356

Q37682510-1B11D624-2FFF-4FB4-B9D7-781BF6F4F88A

P407

Q37682510-E7B4D470-3CAE-4F56-A410-01BD07C8C9E2

P433

Q37682510-E976A733-754D-45FB-8CBB-7563AB08618E

P478

Q37682510-6B9871D3-690E-498F-9624-F208C056E5A2

P577

Q37682510-A9B17B5F-4020-442E-9C38-5DB27C9DA26E

P5875

Q37682510-A8FD62C3-11BF-481C-BF55-AE23A445085B

P698

Q37682510-1EB814D5-4748-4B5E-99BA-81A9373A7286

P921

Q37682510-657FE34C-0F6C-4090-A14D-4745A8B51582

Q37682510-E0E90633-45EF-44E2-9469-B7B4F406DA6A

Q37682510-EDA8703F-6480-43A1-8633-D74379737589

P932

Q37682510-C6406DD8-9D7F-476B-9CB7-CD9C3D8F3FF6

P356

WJG.V20.I13.3552

P1433

World Journal of Gastroenterology

P1476

Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

@en

P2093

Branislav R Filipovic

http://www.w3.org/2001/XMLSchema#string

Branka F Filipovic

http://www.w3.org/2001/XMLSchema#string

P2860

Psychological issues in inflammatory bowel disease: an overview

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Psychological interventions for treatment of inflammatory bowel disease

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome

Amitriptyline for depression

Budesonide for induction of remission in Crohn's disease

Antidepressants and inflammatory bowel disease: a systematic review

Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece

Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

P304

3552-3563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I13.3552

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261410242

http://www.w3.org/2001/XMLSchema#string

P698

24707138

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

3974522

http://www.w3.org/2001/XMLSchema#string